More on ONC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $369.16 |
|
|||
| Open | $375.00 | ||||
| 52 Wk High | $0.35 | ||||
| 52 Wk Low | $0.35 | ||||
| Day High | $379.48 | ||||
| Day Low | $374.37 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 252,600 | ||||
- BeOne Medicines renews CLL drug access deal for low-income nations
- BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
- Form 4 BeOne Medicines Ltd. For: Aug 11 Filed by: Lee Chan Henry
- Form 4 BeOne Medicines Ltd. For: Aug 10 Filed by: OYLER JOHN
- BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
- BeOne Medicines (ONC) PT Raised to $405 at Morgan Stanley
- BeOne Medicines (ONC) PT Raised to $454 at TD Cowen
- BeOne Medicines (ONC) PT Raised to $418 at Truist Securities
- BeOne Medicines (ONC) PT Raised to $430 at Guggenheim
- BeOne Medicines (ONC) PT Lowered to $450 at RBC Capital
Entities mentioned with ONC
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Canaccord Genuity | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
